Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01323452
What this trial is testing

Entecavir for Chronic Hepatitis B

Who this might be right for
Entecavir for Chronic Hepatitis B Patients
Foundation for Liver Research 418
Not applicableStudy completedNCT00001116
What this trial is testing

Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT01878799
What this trial is testing

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Who this might be right for
Hepatitis CHIV
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT01499199
What this trial is testing

The Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 13
Not applicableUnknownNCT00002301
What this trial is testing

Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Astra USA
Post-approval studies (Phase 4)Study completedNCT04141930
What this trial is testing

Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle

Who this might be right for
InfluenzaRespiratory Viral Infection
University of Washington 481
Not applicableStudy completedNCT01480492
What this trial is testing

Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection

Who this might be right for
HBeAg Positive Chronic Hepatitis B Infection
Cz Li 56
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Not applicableStudy completedNCT03313154
What this trial is testing

Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

Who this might be right for
Psychiatric DisordersCognitive ImpairmentChronic Hepatitis c
Azienda Ospedaliero Universitaria di Cagliari 100
Not applicableStudy completedNCT01531166
What this trial is testing

A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon

Who this might be right for
Chronic Hepatitis B
Yonsei University 500
Not applicableStudy completedNCT00814879
What this trial is testing

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Who this might be right for
Acquired Immune Deficiency SyndromeAIDSHuman Immunodeficiency Virus+1 more
Yale University 60
Early research (Phase 1)Study completedNCT01433835
What this trial is testing

Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers

Who this might be right for
Healthy Adult Subjects
Microbiotix, Inc. 48
Post-approval studies (Phase 4)UnknownNCT04225325
What this trial is testing

Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).

Who this might be right for
HIV-1-infection
ADRIANO LAZZARIN, MD 112
Large-scale testing (Phase 3)Study completedNCT04292899
What this trial is testing

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)

Who this might be right for
COVID-19
Gilead Sciences 4,891
Early research (Phase 1)Study completedNCT02173574
What this trial is testing

Two-way Interaction Between Alisporivir and EDP239

Who this might be right for
Hepatitis C Virus
Enanta Pharmaceuticals, Inc 42
Early research (Phase 1)Ended earlyNCT02826018
What this trial is testing

ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis BChronic Hepatitis BHepatitis B, Chronic+2 more
Alnylam Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT03250910
What this trial is testing

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
National Taiwan University Hospital 228
Testing effectiveness (Phase 2)Study completedNCT01587586
What this trial is testing

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
PharmaEssentia 107
Not applicableStudy completedNCT07702396
What this trial is testing

Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Who this might be right for
Heptatitis C
Indus Hospital and Health Network 192
Testing effectiveness (Phase 2)Study completedNCT04337918
What this trial is testing

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection

Who this might be right for
Corona Virus Infection
Sanotize Research and Development corp. 143
Next Page